Company / Cash per Share
Lexaria Bioscience Corp. Cash per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.02
FY2022
5-year range
$0.43 / $1.02
FY2018-FY2022
Trend
+135.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 7 years, ranging from $0.01 in FY2017 to $1.02 in FY2022.
Based on SEC 10-K filings.
1.02 in FY2022 with a 5-year CAGR of +188.6%.
Improved from $0.02 to $1.02 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +254.1%
- 5-Year CAGR
- +188.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, cash per share increased 135.5% year-over-year.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $1.02 | +135.5% |
| FY2021 | $0.43 | +2542.5% |
| FY2020 | $0.02 | -28.7% |
| FY2019 | $0.02 | +350.9% |
| FY2017 | $0.01 | -14.5% |
| FY2016 | $0.01 | -71.1% |
| FY2015 | $0.02 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026